U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418229) titled 'Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine' on Feb. 11.
Brief Summary: To evaluate the safety of Sinovac RSV mRNA among participants aged >=18 years
Study Start Date: March 09
Study Type: INTERVENTIONAL
Condition:
RSV
mRNA Vaccine
Intervention:
BIOLOGICAL: Low-dose RSV mRNA vaccine
One dose of RSV mRNA vaccine in low dosage
BIOLOGICAL: High-dose RSV mRNA vaccine
One dose of RSV mRNA vaccine in high dosage
OTHER: Placebo
Participants will receive one dose of normal saline.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sinovac Biotech Co., Ltd
Disclaimer: Curated by HT Syndication....